Pivotal Study of N-acetyl-L-leucine for CACNA1A

Clinical trial NCT07221292 · RECRUITING

Trial details

NCT number: NCT07221292
Sponsor: IntraBio Inc
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

CACNA1A Spinocerebellar Ataxia Type 6 Episodic Ataxia Type 2 Familial Hemiplegic Migraine-1

Start date: 2026-08-17
Primary completion: 2028-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.